
AstraZeneca forum spotlights rare disease care, patient realities
AstraZeneca’s Agham Kapihan highlights rare disease care gaps, PhilHealth coverage limits, and patient experiences during National Rare Disease Week.
Tip: add a year in your query (e.g. Eala 2022) or use the year filter.
51 results for “AstraZeneca”

AstraZeneca’s Agham Kapihan highlights rare disease care gaps, PhilHealth coverage limits, and patient experiences during National Rare Disease Week.
‘This partnership embodies our core belief: the government creates the enabling environment and the private sector provides the innovation and resources.’

The Department of Trade and Industry and AstraZeneca signed an agreement to establish the Philippines’ first Pharma Innovation Hub, starting with an Oncology…

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Philippines is strengthening its partnership with AstraZeneca to expand clinical trials, health innovation and life sciences investments, with the…

The Philippines and AstraZeneca are expanding cooperation on clinical trials, health innovation and life sciences investments to build a regional research hub.

Celebrate World Kidney Day with Mercury Drug's expanded free kidney screenings, now available nationwide. Partnering with AstraZeneca Philippines and Diabetes…


PEZA Director General Tereso O. Panga said more LGUs have shown interest in hosting ecozones, with 34 new and expansion zones worth P14.7 billion proclaimed…

The Philippines is becoming a pharmaceutical hub in Southeast Asia, with the upcoming Pharma Innovation Hub and growing investments from Merck and Royale Life…


The number of Covid-19 cases in the country is on a downward trend, the Department of Health (DOH) reported on Saturday.

The Ayala Group is leading the way in the Philippines by raising cancer awareness in the workplace, offering comprehensive support programs for employees…

Sweden is committed to further increasing its bilateral relationship with the Philippines.

Through innovation, education and collaboration, the company is reshaping perceptions of generic medicines.



The combined approach allows doctors to personalize treatment plans by identifying the specific genetic makeup of a patient’s cancer.